M2rlab-XCELL

M2R Lab is a South Korean biotechnology company focused on the development of innovative cell and exosome-based therapeutics. The company utilizes its proprietary X-CELL platform to engineer exosomes and cell-derived vesicles, enhancing their targeting capabilities and therapeutic payload delivery. M2R Lab's research and development efforts are primarily directed toward oncology, immunology, and regenerative medicine, with a specific focus on natural killer (NK) cells and mesenchymal stem cells (MSCs). By integrating advanced cell engineering with exosome technology, the company aims to provide more effective and safer treatment options for complex diseases such as solid tumors and chronic inflammatory conditions. The company is currently advancing several programs through the pre-clinical stage, targeting high-unmet-need indications.